News

2015 Mar 09

Researchers sequence genome of Classical Hodgkin's lymphoma cells

A team of researchers led by Ethel Cesarman has sequenced the genome of Classical Hodgkin lymphoma, illuminating exactly which proteins are altered in individual patients. Read more

2015 Mar 09

A Different Prescription: Seeking Progress in Women’s Cancers

Meyer Cancer Center director Lewis Cantley discusses progress and treatments for women's cancers. Read more

2015 Mar 05

DNA safeguard may be key in cancer treatment

Ithaca members Marcus Smolka and Haiyuan Yu have developed a new technique to understand the actions of key proteins required for cancer cells to proliferate. Read more

2015 Mar 05

Nobel Laureate Harold Varmus joins Meyer Cancer Center

Harold Varmus, director of the National Cancer Institute (NCI) and co-winner of the Nobel Prize, will join Weill Cornell Medical College as the Lewis Thomas University Professor of Medicine, effective April 1 Read more

2015 Mar 04

Meyer Cancer Center welcomes renowned radiation oncologist Silvia Formenti

Silvia C. Formenti, M.D., will join the Meyer Cancer Center as Associate Director of Radiation Oncology. Read more

2015 Mar 03

Most commonly used treatment for prostate cancer is radiotherapy

New Meyer Cancer Center member Jim C. Hu analyzes treatment options for prostate cancer in this JAMA Oncology study. Read more

2015 Mar 02

Tackling tumors with both brain and brawn

The Meyer Cancer Center’s new associate director of translational research, Howard Fine, will be founding director of a new Brain Tumor Center. Read more

2015 Mar 02

Weill research highlighted at #GU15 conference

The research of several Meyer Cancer Center members was highlighted at the recent ASCO Genitourinary Cancers Symposium Read more

2015 Mar 02

Bartlett family honors Dr. Manish Shah

A $1 million gift from the family of the late Robert Bartlett, D.M.D.,will establish the Bartlett Family Associate Professorship in Gastrointestinal Oncology. Read more

2015 Feb 19

Fighting the War on Cancer

To really stand a chance against cancer, we should focus on more interdisciplinary collaboration, writes biomedical engineer Claudia Fischbach in this guest piece. Read more

2015 Feb 19

Communication networks discovered between tumors and surrounding microenvironment

A research team led by Vivek Mittal has identified complex communication networks between tumors and surrounding blood vessels, immune cells, connective tissue cells and structural cells. Read more

2015 Feb 18

Role of Transplantation in High-Risk CLL

Richard Furman, M.D., talks to OncLive about the role of allogeneic hematopoietic stem cell transplantation in chronic lymphocytic leukemia. Read more

2015 Feb 13

The Treatment Challenges of Neuroendocrine Prostate Cancer

Himisha Beltran, M.D., presented at the Chemotherapy Foundation Symposium about neuroendocrine prostate cancer, a high-risk, lethal subset of disease. Read more

2015 Feb 09

Mantle Cell Lymphoma Treatment Challenges

Associate professor Jia Ruan, M.D., Ph.D., talks to OncLive about initial treatment methods for mantle cell lymphoma (MCL). Read more

2015 Feb 09

Entrepreneurship in Action

Several Meyer Cancer Center members have been featured in the latest issue of Weill Cornell Medicine magazine. Read more

2015 Feb 07

Optimizing Treatment With Ibrutinib in High-Risk CLL

Richard Furman, M.D., director of Weill's CLL Research Center, participates in a panel discussion about therapy for patients with chronic lymphocytic leukemia (CLL) whose tumors harbor a 17p deletion. Read more

2015 Feb 05

Big Data and Bacteria: Mapping the New York Subway’s DNA

Pathologist Christopher Mason and his research team gathered DNA from turnstiles, ticket kiosks, railings and benches in a transit system shared by 5.5 million riders every day. Read more

2015 Feb 04

Onartuzumab for Gastroesophageal Adenocarcinoma

Manish A Shah, M.D., director of gastrointestinal oncology, discusses a recent phase II study of FOLFOX with or without onartuzumab, a MET inhibitor, for the treatment of metastatic gastroesophageal adenocarcinoma. Read more

2015 Feb 03

Researchers enthusiastic over Obama's new $215m precision medicine initiative

Mark Rubin, director of Weill Cornell's Institute for Precision Medicine, recently traveled to the White House as President Barack Obama unveiled a new $215m precision medicine initiative. Read more

2015 Feb 02

Advanced technology for more precise treatment of brain and spine tumors

Image-guided radiotherapy (IGRT) delivers highly accurate doses of radiation therapy to targeted areas in the brain while maximizing patient comfort in a procedure called stereotactic radiosurgery. Read more

News

Researchers sequence genome of Classical Hodgkin's lymphoma cells

A Different Prescription: Seeking Progress in Women’s Cancers

DNA safeguard may be key in cancer treatment

Nobel Laureate Harold Varmus joins Meyer Cancer Center

Meyer Cancer Center welcomes renowned radiation oncologist Silvia Formenti

Most commonly used treatment for prostate cancer is radiotherapy

Tackling tumors with both brain and brawn

Weill research highlighted at #GU15 conference

Bartlett family honors Dr. Manish Shah

Fighting the War on Cancer

Communication networks discovered between tumors and surrounding microenvironment

Role of Transplantation in High-Risk CLL

The Treatment Challenges of Neuroendocrine Prostate Cancer

Mantle Cell Lymphoma Treatment Challenges

Entrepreneurship in Action

Optimizing Treatment With Ibrutinib in High-Risk CLL

Big Data and Bacteria: Mapping the New York Subway’s DNA

Onartuzumab for Gastroesophageal Adenocarcinoma

Researchers enthusiastic over Obama's new $215m precision medicine initiative

Advanced technology for more precise treatment of brain and spine tumors

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters